Climb Bio PT raised to $32 from $20 by BTIG
BTIG raised its price target for Climb Bio to $32.00 per share from $20.00, while maintaining a Buy rating.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.